Neuroinflammation in treated HIV-positive individuals: A TSPO PET study

Autor: Courtney A. Bishop, Paul M. Matthews, Peter Kelleher, Qi Guo, James H. Cole, Roger N. Gunn, Alan Winston, Jaime H. Vera, Nicola J. Kalk, Louise Greathead, Eugenii A. Rabiner, Adriano Boasso
Přispěvatelé: Medical Research Council (MRC)
Jazyk: angličtina
Rok vydání: 2016
Předmět:
Male
0301 basic medicine
Pathology
Pyridines
1702 Cognitive Sciences
Hippocampus
HIV Infections
Neuropsychological Tests
Brain mapping
0302 clinical medicine
Positron Emission Tomography Computed Tomography
Acetamides
PERIPHERAL BENZODIAZEPINE-RECEPTOR
Carbon Radioisotopes
IN-VIVO
MICROBIAL TRANSLOCATION
PROTEIN 18 KDA
Brain Mapping
ACTIVE ANTIRETROVIRAL THERAPY
biology
Brain
MULTIPLE-SCLEROSIS
White Matter
Diffusion Tensor Imaging
Globus pallidus
medicine.anatomical_structure
Anti-Retroviral Agents
RNA
Viral

Chemokines
medicine.symptom
Life Sciences & Biomedicine
Adult
DNA
Bacterial

medicine.medical_specialty
Clinical Neurology
CD4-CD8 Ratio
Inflammation
DNA
Ribosomal

Article
White matter
03 medical and health sciences
POSITRON-EMISSION-TOMOGRAPHY
CEREBROSPINAL-FLUID
Receptors
GABA

Internal medicine
medicine
Translocator protein
Humans
Neuroinflammation
Science & Technology
Neurology & Neurosurgery
business.industry
Multiple sclerosis
1103 Clinical Sciences
INFECTED SUBJECTS
medicine.disease
IMMUNE ACTIVATION
030104 developmental biology
Endocrinology
biology.protein
Neurosciences & Neurology
Neurology (clinical)
Radiopharmaceuticals
1109 Neurosciences
business
Biomarkers
030217 neurology & neurosurgery
Popis: OBJECTIVE: To explore the effects of microglial activation on brain function and structure, and its relationship with peripheral inflammatory markers, in treated, HIV-positive individuals, using in vivo [(11)C]PBR28 PET (to measure the 18 kDa translocator protein [TSPO]). METHODS: Cognitively healthy HIV-positive individuals on suppressive antiretroviral therapy and HIV-negative individuals (controls) underwent brain [(11)C]PBR28 PET and MRI. HIV-positive patients completed neuropsychological testing and CSF testing for chemokines. The concentration of bacterial ribosomal 16sDNA in plasma was measured as a marker of microbial translocation. RESULTS: HIV-positive individuals showed global increases in TSPO expression compared to controls (corrected p < 0.01), with significant regional increases in the parietal (p = 0.001) and occipital (p = 0.046) lobes and in the globus pallidus (p = 0.035). TSPO binding in the hippocampus, amygdala, and thalamus were associated with poorer global cognitive performance in tasks assessing verbal and visual memory (p < 0.05). Increased TSPO binding was associated with increased brain white matter diffusion MRI mean diffusivity in HIV-positive individuals, a lower CD4/CD8 ratio, and both high pretreatment HIV RNA and plasma concentration ribosomal 16s DNA (p < 0.05). CONCLUSIONS: Cognitively healthy HIV-positive individuals show evidence for a chronically activated brain innate immune response and elevated blood markers of microbial translocation despite effective control of plasma viremia. Increased brain inflammation is associated with poorer cognitive performance and white matter microstructural pathology, suggesting a possible role in cognitive impairments found in some HIV-positive patients despite effective treatment.
Databáze: OpenAIRE